This review summarizes the latest advances in treating and preventing Clostridium difficile
infection (CDI), the most common infectious disease cause of nosocomial diarrhea in adults …

This Review summarizes the latest advances in the treatment and prevention of Clostridium
difficile infection (CDI), which is now the most common health-care-associated infection in …

Clostridium difficile infection (CDI) has increased in incidence and severity, and is now
among the most common nosocomial infections. Several agents are available for the initial …

Clostridioides difficile is the most prevalent pathogen of nosocomial diarrhea. In the United
States, over 450,000 cases of C. difficile infection (CDI), responsible for more than 29,000 …

Clostridioides difficile infections (CDIs) have decreased in the past years, but since 2021,
some hospitals have reported an increase in CDI rates. CDI remains a global concern and …

Clostridium difficile is an anaerobic, gram positive, sporulating, toxin-producing bacillus
which causes a spectrum of clinical disease ranging from an asymptomatic carrier state to …

For many years, it has been known that Clostridium difficile (CD) is the primary cause of
health-care-associated infectious diarrhea, afflicting approximately 1% of hospitalized …

Current and future management of Clostridioides difficile infection (CDI) including antibiotic
treatment is increasingly focused on preventive strategies, either prevention of recurrent CDI …

Background Clostridioides difficile infection (CDI) remains the leading cause of healthcare-
associated diarrhoea, despite existing guidelines for infection control measures and …

Clostridioides difficile causes a range of debilitating intestinal symptoms that may be fatal. It
is particularly problematic as a hospital-acquired infection, causing significant costs to the …